Camurus AB, Author at V3 Media

Camurus NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

No Comments

PDUFA target action date set to 18 December 2026 , /PRNewswire/ — Camurus (NASDAQ STO: CAMX)…